208 related articles for article (PubMed ID: 27280688)
1. Curcumin: A new candidate for melanoma therapy?
Mirzaei H; Naseri G; Rezaee R; Mohammadi M; Banikazemi Z; Mirzaei HR; Salehi H; Peyvandi M; Pawelek JM; Sahebkar A
Int J Cancer; 2016 Oct; 139(8):1683-95. PubMed ID: 27280688
[TBL] [Abstract][Full Text] [Related]
2. Curcumin and treatment of melanoma: The potential role of microRNAs.
Lelli D; Pedone C; Sahebkar A
Biomed Pharmacother; 2017 Apr; 88():832-834. PubMed ID: 28167449
[TBL] [Abstract][Full Text] [Related]
3. Curcumin as a MicroRNA Regulator in Cancer: A Review.
Momtazi AA; Shahabipour F; Khatibi S; Johnston TP; Pirro M; Sahebkar A
Rev Physiol Biochem Pharmacol; 2016; 171():1-38. PubMed ID: 27457236
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo anti-tumoral effect of curcumin against melanoma cells.
Odot J; Albert P; Carlier A; Tarpin M; Devy J; Madoulet C
Int J Cancer; 2004 Sep; 111(3):381-7. PubMed ID: 15221965
[TBL] [Abstract][Full Text] [Related]
5. An update on Curcuma as a functional food in the control of cancer and inflammation.
Schaffer M; Schaffer PM; Bar-Sela G
Curr Opin Clin Nutr Metab Care; 2015 Nov; 18(6):605-11. PubMed ID: 26418821
[TBL] [Abstract][Full Text] [Related]
6. Targeting cancer stem cells by curcumin and clinical applications.
Li Y; Zhang T
Cancer Lett; 2014 May; 346(2):197-205. PubMed ID: 24463298
[TBL] [Abstract][Full Text] [Related]
7. Curcumin and cancer: an "old-age" disease with an "age-old" solution.
Anand P; Sundaram C; Jhurani S; Kunnumakkara AB; Aggarwal BB
Cancer Lett; 2008 Aug; 267(1):133-64. PubMed ID: 18462866
[TBL] [Abstract][Full Text] [Related]
8. Curcumin: a Polyphenol with Molecular Targets for Cancer Control.
Qadir MI; Naqvi ST; Muhammad SA
Asian Pac J Cancer Prev; 2016; 17(6):2735-9. PubMed ID: 27356682
[TBL] [Abstract][Full Text] [Related]
9. Orally Administered Chitosan-Coated Polycaprolactone Nanoparticles Containing Curcumin Attenuate Metastatic Melanoma in the Lungs.
Loch-Neckel G; Santos-Bubniak L; Mazzarino L; Jacques AV; Moccelin B; Santos-Silva MC; Lemos-Senna E
J Pharm Sci; 2015 Oct; 104(10):3524-34. PubMed ID: 26085173
[TBL] [Abstract][Full Text] [Related]
10. Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment.
Naksuriya O; Okonogi S; Schiffelers RM; Hennink WE
Biomaterials; 2014 Mar; 35(10):3365-83. PubMed ID: 24439402
[TBL] [Abstract][Full Text] [Related]
11. A Comprehensive Review on Pharmacotherapeutics of Three Phytochemicals, Curcumin, Quercetin, and Allicin, in the Treatment of Gastric Cancer.
Haghi A; Azimi H; Rahimi R
J Gastrointest Cancer; 2017 Dec; 48(4):314-320. PubMed ID: 28828709
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms underlying chemopreventive potential of curcumin: Current challenges and future perspectives.
Kumar G; Mittal S; Sak K; Tuli HS
Life Sci; 2016 Mar; 148():313-28. PubMed ID: 26876915
[TBL] [Abstract][Full Text] [Related]
13. New mechanisms and therapeutic potential of curcumin for colorectal cancer.
Villegas I; Sánchez-Fidalgo S; Alarcón de la Lastra C
Mol Nutr Food Res; 2008 Sep; 52(9):1040-61. PubMed ID: 18655004
[TBL] [Abstract][Full Text] [Related]
14. Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials.
Strimpakos AS; Sharma RA
Antioxid Redox Signal; 2008 Mar; 10(3):511-45. PubMed ID: 18370854
[TBL] [Abstract][Full Text] [Related]
15. Tumor growth inhibition through targeting liposomally bound curcumin to tumor vasculature.
Mondal G; Barui S; Saha S; Chaudhuri A
J Control Release; 2013 Dec; 172(3):832-40. PubMed ID: 24036260
[TBL] [Abstract][Full Text] [Related]
16. Anti-proliferative effect of curcumin on melanoma cells is mediated by PDE1A inhibition that regulates the epigenetic integrator UHRF1.
Abusnina A; Keravis T; Yougbaré I; Bronner C; Lugnier C
Mol Nutr Food Res; 2011 Nov; 55(11):1677-89. PubMed ID: 22045655
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in curcumin nanoformulation for cancer therapy.
Lee WH; Loo CY; Young PM; Traini D; Mason RS; Rohanizadeh R
Expert Opin Drug Deliv; 2014 Aug; 11(8):1183-201. PubMed ID: 24857605
[TBL] [Abstract][Full Text] [Related]
18. Antiglioma activity of curcumin-loaded lipid nanoparticles and its enhanced bioavailability in brain tissue for effective glioblastoma therapy.
Kundu P; Mohanty C; Sahoo SK
Acta Biomater; 2012 Jul; 8(7):2670-87. PubMed ID: 22484149
[TBL] [Abstract][Full Text] [Related]
19. Curcumin as a therapeutic agent in leukemia.
Kouhpeikar H; Butler AE; Bamian F; Barreto GE; Majeed M; Sahebkar A
J Cell Physiol; 2019 Aug; 234(8):12404-12414. PubMed ID: 30609023
[TBL] [Abstract][Full Text] [Related]
20. C6 ceramide potentiates curcumin-induced cell death and apoptosis in melanoma cell lines in vitro.
Yu T; Li J; Sun H
Cancer Chemother Pharmacol; 2010 Oct; 66(5):999-1003. PubMed ID: 20521051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
